Top

Breast Cancer Research and Treatment

Published in:

01-03-2002

Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRI

Published in: Breast Cancer Research and Treatment | Issue 2/2002

Title: Imaging in Evaluation of Response to Neoadjuvant Breast Cancer Treatment Benefits of MRI
Publication date: 01-03-2002
Published in: Breast Cancer Research and Treatment / Issue 2/2002
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1023/A:1014856713942

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2002

Instructions for Authors

The Effect of Flutamide and Tamoxifen on Sex Hormone-Induced Mammary Carcinogenesis and Pituitary Adenoma

Reproductive Factors and Breast Cancer Risk. Do They Differ According to Age at Diagnosis?

Loss of Co-ordinate Expression of Progesterone Receptors A and B is an Early Event in Breast Carcinogenesis

Alterations in Cellular Retinol Metabolism Contribute to Differential Retinoid Responsiveness in Normal Human Mammary Epithelial Cells Versus Breast Cancer Cells

Letter to the Editor

Keynote webinar | Spotlight on antibody–drug conjugates in cancer